Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Antimicrobial Peptides As Potent Compounds for Reduction of Covid-19 Infection Publisher



Zarezardini H1, 2, 3 ; Ferdosian F1, 4 ; Soltaninejad H5 ; Zahedi M6 ; Memarpooryazdi M7 ; Hamidieh AA8 ; Aghaeimeybodi F9 ; Zarezadeh M10 ; Eshaghi FS11 ; Jabinian F12 ; Dehghanbaghi N13 ; Mirakhor M14 ; Khnjarpanah Z14
Authors
Show Affiliations
Authors Affiliations
  1. 1. Hematology and Oncology Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  2. 2. Department of Sciences, Farhangian University, Isfahan, Iran
  3. 3. Medical Nanotechnology & Tissue Engineering Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  4. 4. Department of Pediatrics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  5. 5. Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
  6. 6. Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  7. 7. Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran
  9. 9. Iran Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  10. 10. Health Policy and Management Research Center, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  11. 11. Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  12. 12. Department of Operating Room and Anesthesiology, School of Allied Medical Sciences, Yazd, Iran
  13. 13. Department of Biology, Faculty of Science, Science and Art University, Iran
  14. 14. Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Source: Bulletin of Pharmaceutical Sciences. Assiut Published:2021


Abstract

COVID-19 is an infectious disease caused by a new identified coronavirus in China, SARSCOV2. There are no efficient treatments for COVID-19. Therefore, it is essential to investigate new therapies for this problem. Due to specific mechanism for inhibition of microbial growth, antimicrobial peptides can be considered as one of the best therapies in this field. Antimicrobial peptides (AMPs) are important agents that are made by the immune system in response to pathogens. This kind of immune response exists in all animal categories from prokaryotes to humans. Different types of AMPs have been identified and isolated from various organisms from bacteria to humans. So far, 190 antiviral peptides with antiviral effects have been extracted and introduced from various animal sources. These natural compounds and their derivatives, e.g. synthetic peptides, can be considered as new therapeutic goals in COVID-19. In this review, we assessed these peptides in different animal categories as well as synthetic peptides and the possibility of using these compounds in the treatment of COVID-19. © 2021 Assiut University. All rights reserved.